These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30303650)

  • 61. Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease.
    Navarro-González JF; Sánchez-Niño MD; Donate-Correa J; Martín-Núñez E; Ferri C; Pérez-Delgado N; Górriz JL; Martínez-Castelao A; Ortiz A; Mora-Fernández C
    Diabetes Care; 2018 Aug; 41(8):1817-1820. PubMed ID: 29866645
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Utilization patterns of antihypertensive drugs among the chronic kidney disease population in the United States: a cross-sectional analysis of the national health and nutrition examination survey.
    Sonawane KB; Qian J; Hansen RA
    Clin Ther; 2015 Jan; 37(1):188-96. PubMed ID: 25524390
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mechanism by which chronic kidney disease causes cardiovascular disease and the measures to manage this phenomenon.
    Kusano E
    Clin Exp Nephrol; 2011 Oct; 15(5):627-633. PubMed ID: 21629994
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High serum soluble α-Klotho levels in patients with autosomal dominant polycystic kidney disease.
    Sari F; Inci A; Dolu S; Ellidag HY; Cetinkaya R; Ersoy FF
    J Investig Med; 2017 Feb; 65(2):358-362. PubMed ID: 27733443
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serum Soluble Klotho Level Is Associated with Abdominal Aortic Calcification in Patients on Maintenance Hemodialysis.
    Cai H; Lu R; Zhang M; Pang H; Zhu M; Zhang W; Ni Z; Qian J; Yan Y
    Blood Purif; 2015; 40(2):120-6. PubMed ID: 26159932
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Soluble serum Klotho levels in healthy subjects. Comparison of two different immunoassays.
    Pedersen L; Pedersen SM; Brasen CL; Rasmussen LM
    Clin Biochem; 2013 Aug; 46(12):1079-1083. PubMed ID: 23707222
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors.
    Dattolo PC; Gallo P; Michelassi S; Paudice N; Cannavò R; Romoli E; Fani F; Tsalouchos A; Mehmetaj A; Ferro G; Sisca S; Pizzarelli F
    J Nephrol; 2016 Dec; 29(6):809-815. PubMed ID: 27015900
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Mineral metabolism in patients on chronic peritoneal dialysis].
    Ceballos O ML; Rojo L A; Azócar P M; Ibacache M MJ; Delucchi B A; Quiroz Z L; Irarrázabal M C; Delgado B I; Ugarte P F; Cano Sch F
    Rev Chil Pediatr; 2014 Feb; 85(1):31-9. PubMed ID: 25079181
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
    JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pentoxifylline plus ACEIs/ARBs for proteinuria and kidney function in chronic kidney disease: a meta-analysis.
    Liu D; Wang LN; Li HX; Huang P; Qu LB; Chen FY
    J Int Med Res; 2017 Apr; 45(2):383-398. PubMed ID: 28415944
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New Insights into the Role of FGF-23 and Klotho in Cardiovascular Disease in Chronic Kidney Disease Patients.
    Memmos E; Papagianni A
    Curr Vasc Pharmacol; 2021; 19(1):55-62. PubMed ID: 32310050
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prescriptions for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and monitoring of serum creatinine and potassium in patients with chronic kidney disease.
    Wang PT; Huang YB; Lin MY; Chuang PF; Hwang SJ
    Kaohsiung J Med Sci; 2012 Sep; 28(9):477-83. PubMed ID: 22974666
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of Sevelamer on Serum Levels of Klotho and Soluble Tumor Necrosis Factor-like Weak Inducer of Apoptosis in Rats With Adenine-induced Chronic Kidney Disease.
    Golmohamadi Z; Argani H; Ghorbanihaghjo A; Rashtchizadeh N; Bargahi N; Mesgari M; Sanajou D
    Iran J Kidney Dis; 2018 Oct; 12(5):281-287. PubMed ID: 30367019
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Risk factors for pulmonary hypertension at the predialysis stage of chronic kidney disease].
    Rudenko TE; Vasilyeva MP; Solomakhina NI; Kutyrina IM
    Ter Arkh; 2016; 88(6):33-39. PubMed ID: 27296259
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dual renin-angiotensin system blockade for nephroprotection.
    Ruggenenti P
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S43-S45. PubMed ID: 28577742
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevalence of chronic kidney disease and its risk factors among family practice patients in Lithuania.
    Bumblyte IA; Zilinskiene A; Vanholder R; Valius L; Kuzminskis V
    Clin Nephrol; 2012 Sep; 78(3):198-206. PubMed ID: 22874108
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacologic Issues in treating hypertension in CKD.
    Sica DA
    Adv Chronic Kidney Dis; 2011 Jan; 18(1):42-7. PubMed ID: 21224029
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
    Lin YC; Lin JW; Wu MS; Chen KC; Peng CC; Kang YN
    PLoS One; 2017; 12(12):e0188975. PubMed ID: 29240784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.